Travere Therapeutics is awaiting an FDA decision on a label expansion for FILSPARI in focal segmental glomerulosclerosis, a ...
A year after revealing his “Liberation Day” trade policy initiatives, U.S. President Donald Trump is set to announce tariffs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results